跳至主要内容
临床试验/JPRN-UMIN000010463
JPRN-UMIN000010463已完成1 期

A clinical study of an oncolytic herpes simplex type 1 (HSV-1) G47delta for patients with castration resistant prostate cancer - A clinical study of an oncolytic HSV-1 G47delta for patients with castration resistant prostate cancer

The University of Tokyo Hospital0 个研究点目标入组 9 人开始时间: 2013年4月12日最近更新:

试验速览

阶段
1 期
状态
已完成
入组人数
9

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Male

入选标准

  • 未提供

排除标准

  • -Administration of other clinical study drugs within 30 days of G47delta administration -Known HIV seropositivity -Current diagnosis of any medical or psychological condition that might interfere with the subject's ability to participate -Blood test results outside protocol specified limits -Evidence of active herpes infection -Current diagnosis of any active malignant tumor -Active uncontrolled infection that precludes surgery -History of alcohol or other drug abuse -Allergy to anti-HSV drug (acyclovir) -Administration of any anticancer drugs within 30 days of G47delta administration -Administration of any anti-androgen drugs within 30 days of G47delta administration -Conditions considered inadequate for the subject to be enrolled in the study

研究者

相似试验